Sorry, this activity has expired and is no longer available for CME credit. You may still enjoy the program.
CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by educational grants from Alimera Sciences, Inc.; Allergan, Inc.; Bausch + Lomb; Carl Zeiss Meditec, Inc.; EyePoint Pharmaceuticals, Inc.; Genentech, Inc.; and Optos North America.
Target Audience: The intended audience for this activity is retina specialists and other health care professionals involved in the treatment of patients with diabetic retinal disease.
Learning Objectives: Upon successful completion of this activity, participants should be better able to:
- Review recent innovations in diagnostic imaging for diabetic retinal diseases.
- Assess the evidence for the optimal use of conventional, new, and emerging medical treatments for diabetic retinal diseases.
- Evaluate new devices and techniques used in vitreoretinal surgery.
Activity Chair:
Rishi P. Singh, MD
Staff Physician, Cole Eye Institute
Medical Director, Clinical Systems Office
Cleveland Clinic
Associate Professor of Ophthalmology
Case Western Reserve University
Cleveland, OH
Faculty:
Sophie J. Bakri, MD
Professor of Ophthalmology
Mayo Clinic
Rochester, MN
Lisa J. Faia, MD
Associated Retinal Consultants
Royal Oak, MI
Victor H. Gonzalez, MD
Adjunct Professor
Department of Ophthalmology
Department of Human Genetics
UT Houston
Houston, TX
Andrew A. Moshfeghi, MD, MBA
Director, Vitreoretinal Surgery & Medical Retina Fellowships
Director, Clinical Trials Unit
Associate Professor of Ophthalmology
USC Roski Eye Institute
Keck School of Medicine
University of Southern California
Los Angeles, CA
Sumit Sharma, MD
Cole Eye Institute
Cleveland Clinic
Cleveland, OH
Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, March 21, 2019 through March 20, 2020.
How to Participate in This Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view content, and complete the CME posttest and evaluation. Provide only one (1) answer for each question. A satisfactory score is defined as answering 4 out of 6 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Activity Chair and Faculty report the following relationship(s):
Sophie J. Bakri, MD
Consulting Fee: Allergan, Genentech, Novartis, pSivida, Zeiss
Lisa J. Faia, MD
Consulting Fee: Allergan, Genentech, Santen
Speakers Bureau: AbbVie, Allergan
Victor H. Gonzalez, MD
Consulting Fee: AbbVie, Alcon/Novartis, Alimera, Allergan, Bausch + Lomb, Bayer, Beaver Visitec, Genentech, PanOptica, Regeneron, Santen, ThromboGenics, Topcon, Valeant
Contracted Research: AbbVie, Alcon/Novartis, Alimera, Allegro, Allergan, Apellis, Astellas, Boehringer Ingelheim, Chengdu Kanghong, Clearside, DRCR.net, EyeGate, Genentech, Graybug, Iconic, InSite Vision, Mallinckrodt ARD Inc., Opternative, Opthea, PanOptica, Regeneron, Santen, 60° Pharmaceuticals, ThromboGenics, Topcon, Valeant
Ownership Interest: Alimera, PanOptica
Andrew A. Moshfeghi, MD, MBA
Consulting Fee: Alcon, Allegro, Allergan, Clearside, EyePoint, Genentech/Roche, Novartis, Pr3vent, Regeneron, Valeant/Bausch + Lomb
Contracted Research: Genentech/Roche, Regeneron
Ownership Interest: OptiSTENT, Pr3vent, Visunex
Sumit Sharma, MD
Consulting Fee: EyePoint
Rishi P. Singh, MD
Consulting Fee: Alcon, Genentech, Optos, Regeneron, Zeiss
Contracted Research: Alcon, Apellis, Genentech, Regeneron
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com